Liver function assessment using magnetic resonance imaging with gadoxetic acid administration

Liver function assessment using magnetic resonance imaging with gadoxetic acid administration

Bibliographic Details
Main Authors:	Levick, C, Pavlides, M, Robson, M, Neubauer, S, Barnes, E
Format:	Conference item
Published:	Elsevier 2018

Similar Items

Liver-specific gadoxetic acid-enhanced magnetic resonance for focal lesion evaluation
by: P.E. Cossio-Torrico, et al.
Published: (2015-10-01)

Magnetic resonance imaging of liver tumors using gadoxetic acid (Gd-EOB-DTPA) - pilot study
by: Pola Borusewicz, et al.
Published: (2019-08-01)

Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases
by: B. G. Sibinga Mulder, et al.
Published: (2018-11-01)

Magnetic resonance assessment of portal hypertension and liver function
by: Levick, C
Published: (2019)

Diagnosis of cholecystocolonic fistula using gadoxetic acid - magnetic resonance cholangiography
by: A B Mourri, et al.
Published: (2015-09-01)

Multi-parametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
by: Pavlides, M, et al.
Published: (2017)

Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases.
by: Lihua Chen, et al.
Published: (2012-01-01)

Reply to: "Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: a cautionary note on a promising technique".
by: Pavlides, M, et al.
Published: (2016)

Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
by: Pavlides, M, et al.
Published: (2015)

Comparison of gadoxetic acid and gadobenate dimeglumine, liver-specific contrast agents used in magnetic resonance imaging in differential diagnosis of liver masses
by: Mehmet Akcicek, et al.
Published: (2020-03-01)

Evaluation of hepatic findings by magnetic resonance after use of gadoxetic acid
by: Marina Cabral deAlmeida, et al.
Published: (2021-03-01)

Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: a proof of concept study
by: Levick, C, et al.
Published: (2019)

Acute transient tachypnea following gadoxetate administration in a rhesus macaque during contrast-enhanced magnetic resonance imaging
by: Nina M. Aiosa, BS, et al.
Published: (2019-10-01)

Emerging artificial intelligence applications in liver magnetic resonance imaging
by: Hill, CE, et al.
Published: (2021)

Gadoxetic acid disodium-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis.
by: Xijiao Liu, et al.
Published: (2013-01-01)

Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease
by: Jayaswal, ANA, et al.
Published: (2020)

Gadoxetic acid-enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C.
by: Hironao Okubo, et al.
Published: (2018-01-01)

Platelet and spleen volume criteria exclude more oesophageal varices needing treatment than Baveno VI criteria with 100% sensitivity
by: Levick, C, et al.
Published: (2018)

Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study.
by: Christina Levick, et al.
Published: (2019-01-01)

A radiomics model based on preoperative gadoxetic acid–enhanced magnetic resonance imaging for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma
by: Changfeng Li, et al.
Published: (2023-07-01)

Gadoxetic acid-enhanced magnetic resonance imaging predicts hyperbilirubinemia induced by glecaprevir during hepatitis C virus treatment
by: Hironao Okubo, et al.
Published: (2022-05-01)

The MR imaging diagnosis of liver diseases using gadoxetic acid: Emphasis on hepatobiliary phase
by: Woo Kyoung Jeong, et al.
Published: (2013-12-01)

Second-line Sonazoid-enhanced ultrasonography for Liver Imaging Reporting and Data System category 3 and 4 on gadoxetate-enhanced magnetic resonance imaging
by: Yeun-Yoon Kim, et al.
Published: (2022-07-01)

Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver Resection
by: Na Reum Kim, et al.
Published: (2023-07-01)

Preoperative Prediction of Cytokeratin 19 Expression for Hepatocellular Carcinoma with Deep Learning Radiomics Based on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging
by: Chen Y, et al.
Published: (2021-07-01)

Mathematical models for biomarker calculation of drug-induced liver injury in humans and experimental models based on gadoxetate enhanced magnetic resonance imaging.
by: Markus Karlsson, et al.
Published: (2023-01-01)

Effect of Gadoxetic Acid on Quantification of Hepatic Steatosis Using Magnetic Resonance Spectroscopy: A Prospective Study
by: Ju Won Kim, et al.
Published: (2017-04-01)

Pharmacoeconomic Study on the Application of Magnetic Resonance Imaging with Gadoxetic Acid in Addition to Contrast-Enhanced Computed Tomography in Diagnosis of Hepatocellular Carcinoma
by: G. G. Kаrmаzаnovsky, et al.
Published: (2021-11-01)

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
by: Banerjee, R, et al.
Published: (2014)

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.
by: Banerjee, R, et al.
Published: (2014)

The imaging findings of Peliosis hepatis on gadoxetic acid enhanced MRI
by: Morikatsu Yoshida, MD, et al.
Published: (2020-08-01)

Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
by: Xiang Li, et al.
Published: (2015-01-01)

T2*magnetic resonance imaging is more sensitive than histology and serum ferritin for the assessment of iron overload in patients with NAFLD
by: Pavlides, M, et al.
Published: (2014)

Evaluation of high temporal resolution magnetic resonance imaging of the liver with gadoxetate disodium in combination with compressed sensing and parallel imaging under single breath-holding using a 1.5-T magnetic resonance system
by: Fumiaki Fukamatsu, et al.
Published: (2024-03-01)

Gadolinium deposition in the liver and brain in a rat model with liver fibrosis after intravenous administration of gadoxetate disodium
by: Peiying Wei, et al.
Published: (2024-03-01)

Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI
by: Kyoung Doo Song, et al.
Published: (2015-06-01)

Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging
by: Yidi Chen, et al.
Published: (2022-08-01)

Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation
by: Kartik S. Jhaveri, et al.
Published: (2023-02-01)

Spleen T1 and spleen diameter criteria can identify and exclude oesophageal varices accurately
by: Levick, C, et al.
Published: (2019)

A case of focal nodular hyperplasia-like lesion presenting unusual signal intensity on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance image
by: Kumi Ozaki, MD, PhD, et al.
Published: (2023-09-01)